作者
Seung‐Jun Lee,Jung‐Joon Cha,Woong Choi,Wang Soo Lee,Jin‐Ok Jeong,Seonghoon Choi,Yoon-Haeng Cho,Woo Jung Park,Jung‐Kyu Han,Yong‐Joon Lee,Sung‐Jin Hong,Chul‐Min Ahn,Byeong‐Keuk Kim,Young‐Guk Ko,Donghoon Choi,Myeong‐Ki Hong,Yangsoo Jang,Soon Jun Hong,Jung‐Sun Kim,Kyeong Ho Yun,Bum‐Kee Hong,Jung Ho Heo,Won Young Jang,Won‐Yong Shin,Sang Wook Im,Woong Chol Kang,Young Hoon Jung,Yongwhi Park,Sung Yoon Lee,Seung‐Ho Hur,Hyun Hee Choi,Kyoung Jin Kim,Ju Han Kim,Hyun Kuk Kim,Jeong Yong Lee,Ung Kim,Yujung Choi,Seung‐Woon Rha,Yun‐Hyeong Cho
摘要
High-intensity statin is strongly recommended in patients at very high risk (VHR) of atherosclerotic cardiovascular disease (ASCVD). However, concerns about statin-associated adverse effects result in underuse of this strategy in practice.
爱静静
科研小民工
请叫我风吹麦浪
VDC
故意的傲玉
Jenny
杳鸢
iNk
petrichor
Loooong
迟大猫
sutharsons
HEIKU
坚强亦丝
习习
Agernon
星辰坠于海
小林太郎
Leonardi
buno
皖公网安备34019202002308
